HUP0104952A3 - Inhibitors against vascular lipid deposition containing chymase-inhibiting substances - Google Patents

Inhibitors against vascular lipid deposition containing chymase-inhibiting substances

Info

Publication number
HUP0104952A3
HUP0104952A3 HU0104952A HUP0104952A HUP0104952A3 HU P0104952 A3 HUP0104952 A3 HU P0104952A3 HU 0104952 A HU0104952 A HU 0104952A HU P0104952 A HUP0104952 A HU P0104952A HU P0104952 A3 HUP0104952 A3 HU P0104952A3
Authority
HU
Hungary
Prior art keywords
inhibiting substances
inhibitors against
lipid deposition
against vascular
deposition containing
Prior art date
Application number
HU0104952A
Other languages
English (en)
Original Assignee
Daiichi Asubio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Asubio Pharma Co Ltd filed Critical Daiichi Asubio Pharma Co Ltd
Publication of HUP0104952A2 publication Critical patent/HUP0104952A2/hu
Publication of HUP0104952A3 publication Critical patent/HUP0104952A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0104952A 1999-11-01 2000-11-01 Inhibitors against vascular lipid deposition containing chymase-inhibiting substances HUP0104952A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31125799 1999-11-01

Publications (2)

Publication Number Publication Date
HUP0104952A2 HUP0104952A2 (en) 2002-06-29
HUP0104952A3 true HUP0104952A3 (en) 2006-02-28

Family

ID=18014979

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104952A HUP0104952A3 (en) 1999-11-01 2000-11-01 Inhibitors against vascular lipid deposition containing chymase-inhibiting substances

Country Status (11)

Country Link
US (1) US6921766B1 (hu)
EP (1) EP1142586B1 (hu)
KR (1) KR20010100004A (hu)
CN (1) CN1335778A (hu)
AT (1) ATE360423T1 (hu)
AU (1) AU784467B2 (hu)
CA (1) CA2358314A1 (hu)
DE (1) DE60034545T2 (hu)
ES (1) ES2281358T3 (hu)
HU (1) HUP0104952A3 (hu)
WO (1) WO2001032214A1 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062292A1 (fr) 2000-02-22 2001-08-30 Suntory Limited Medicaments preventifs ou therapeutiques pour traiter la fibrose et contenant des inhibiteurs de chymase comme ingredients actifs
AU3413601A (en) 2000-02-22 2001-09-03 Daiichi Asubio Pharma Co., Ltd. Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as the active ingredient
EP1174151B1 (en) 2000-02-22 2007-01-24 Daiichi Asubio Pharma Co., Ltd. Therapeutic treatment of eosinophilia using chymase inhibitors as the active ingredient
WO2003007964A1 (fr) * 2001-07-18 2003-01-30 Nippon Kayaku Kabushiki Kaisha Remede ou agent preventif de cardiopathie ou d'anevrysme contenant un compose d'inhibition de la chymase
WO2004071531A1 (en) * 2003-02-13 2004-08-26 Licentia Oy Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia
KR101278522B1 (ko) 2004-12-02 2013-06-25 다이이찌 산쿄 가부시키가이샤 7원환 화합물 및 그 제조법 및 의약 용도
CN101495463B (zh) 2006-05-31 2012-08-15 第一三共株式会社 7-元环化合物、其制备方法和药物用途
MY153733A (en) * 2008-01-30 2015-03-13 Shin Poong Pharmaceutical Co Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
JP6364362B2 (ja) * 2015-02-17 2018-07-25 学校法人福岡大学 ヒトキマーゼ阻害剤および機能性食品、並びにヒトキマーゼの活性を阻害する方法
JP7072586B2 (ja) 2017-05-24 2022-05-20 ザ ユニバーシティ オブ クィーンズランド 新規な化合物及び使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5199279A (en) 1991-08-13 1993-04-06 Reynolds Martin M Drum contact freezer system and method
JP2982454B2 (ja) 1991-12-20 1999-11-22 王子製紙株式会社 感熱記録体
WO1993025574A1 (en) 1992-06-12 1993-12-23 Pfizer Inc. Inhibitors of angiotensin i chymase(s) including human heart chymase
AU3086095A (en) 1994-07-29 1996-03-04 Suntory Limited Imidazolidine derivative and use thereof
KR100400639B1 (ko) 1995-04-27 2003-12-31 미쯔비시 웰 파마 가부시키가이샤 복소환식아미드화합물및그의의약용도
US5596111A (en) 1995-06-05 1997-01-21 North Dakota State University Method for preparation of carboxylic acids
DE69622148T2 (de) 1995-09-28 2002-10-31 Suntory Ltd Osaka Chinazozin derivate und deren verwendung
AU735545B2 (en) 1996-05-24 2001-07-12 Neurosearch A/S Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
AUPO062696A0 (en) * 1996-06-24 1996-07-18 Fujisawa Pharmaceutical Co., Ltd. Novel compounds
CN1088706C (zh) * 1996-10-25 2002-08-07 卫福有限公司 新型杂环酰胺化合物及其医药用途
CA2321146A1 (en) * 1998-02-17 1999-08-19 Nippon Kayaku Kabushiki Kaisha Novel acetamide derivative and use thereof
AU772771B2 (en) * 1998-08-21 2004-05-06 Daiichi Asubio Pharma Co., Ltd. Quinazoline derivatives and pharmaceutical applications thereof
EP1136488A4 (en) * 1998-12-01 2002-06-12 Meiji Seika Kaisha SF2809-I, II, III. VI, V AND VI COMPOUNDS WITH CHYMASE INHIBITING EFFECT

Also Published As

Publication number Publication date
AU784467B2 (en) 2006-04-06
KR20010100004A (ko) 2001-11-09
EP1142586A4 (en) 2003-03-19
ES2281358T3 (es) 2007-10-01
US6921766B1 (en) 2005-07-26
AU1053601A (en) 2001-05-14
CA2358314A1 (en) 2001-05-10
ATE360423T1 (de) 2007-05-15
WO2001032214A1 (fr) 2001-05-10
HUP0104952A2 (en) 2002-06-29
EP1142586B1 (en) 2007-04-25
EP1142586A1 (en) 2001-10-10
DE60034545D1 (de) 2007-06-06
DE60034545T2 (de) 2007-10-25
CN1335778A (zh) 2002-02-13

Similar Documents

Publication Publication Date Title
GB2354999B (en) Dispenser
AU4961999A (en) Article dispenser
SG93875A1 (en) Showcase
GB9930659D0 (en) Inhibitors of complement activation
AU140442S (en) Dispenser
HUP0104952A2 (en) Inhibitors against vascular lipid deposition containing chymase-inhibiting substances
ZA200110053B (en) Factor via inhibitors.
HK1042695A1 (zh) 蛋白酶抑制劑
AU140425S (en) Dispenser
IL149871A0 (en) Farnesyl tranferase inhibitors
GB9900377D0 (en) Counter tray
IL126671A0 (en) Drug preferably for inhibiting inflammation
AU140586S (en) Dispenser
EP1091783A4 (en) DISTRIBUTOR OF DRUGS
AU7990000A (en) Neuraminidase inhibitors
GB0025714D0 (en) Dispenser
AU141579S (en) Dispenser
GB9909624D0 (en) Coated article
AU2039301A (en) Neuraminidase inhibitors
AU140706S (en) Dispenser
GB9929340D0 (en) Inhibitors
GB9929341D0 (en) Inhibitors
GB9917294D0 (en) Inhibitors
TW487043U (en) Shelf for objects
TW444742U (en) Packing tray